Canavan disease: clinical features and recent advances in research
Hideki Hoshino1, Masaya Kubota
1Department of Pediatrics, University of Tokyo, Tokyo, Japan; Division of Neurology, National Center for Child Health and Development, Tokyo, Japan.
Summary
Canavan disease (CD) is a genetic leukodystrophy caused by ASPA gene mutations, leading to elevated N-acetylaspartic acid (NAA) and neurological issues. Research explores disease mechanisms and potential therapies like gene therapy.
Area of Science:
- Neuroscience
- Genetics
- Biochemistry
Background:
- Canavan disease (CD) is a rare genetic neurodegenerative disorder.
- It affects white matter in the brain, causing spongy degeneration.
- CD results from mutations in the aspartoacylase (ASPA) gene.
Purpose of the Study:
- To review the pathophysiology of Canavan disease.
- To discuss diagnostic approaches.
- To explore current and potential therapeutic strategies.
Main Methods:
- Review of existing literature on Canavan disease.
- Analysis of proposed pathophysiological mechanisms.
- Examination of diagnostic markers like urinary NAA.
- Assessment of preclinical therapeutic studies (mouse/rat models).
Main Results:
- Elevated N-acetylaspartic acid (NAA) is a hallmark of CD, aiding diagnosis.
- Pathophysiology hypotheses include NAA's role in water balance and myelin synthesis.
- Mouse models are crucial for studying white matter degeneration.
- Gene therapy in rat models shows promise with good tolerability and NAA reduction.
Conclusions:
- Canavan disease is characterized by ASPA mutations and elevated NAA.
- Understanding disease mechanisms is key to developing treatments.
- Gene therapy represents a potential future treatment option for CD.
Related Concept Videos
01:21Huntington Disease l: Introduction
82
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show...
82
01:22Lysosomal Hydrolases
3.5K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.5K
01:24Parkinson Disease ll: Pathophysiology
22
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
22
01:15Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
01:21Chronic Pancreatitis II: Pathophysiology
25
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
25
01:23Cystic Fibrosis: Pathogenesis
1.1K
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K